PRESS RELEASE published on 05/08/2024 at 08:31, 1 year 8 months ago Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024 Abivax presents four abstracts on obefazimod for ulcerative colitis and colon cancer model at Digestive Disease Week 2024. The company highlights novel mechanism of action and positive clinical data for obefazimod Abivax Obefazimod Ulcerative Colitis Digestive Disease Week Colon Cancer
PRESS RELEASE published on 05/08/2024 at 08:30, 1 year 8 months ago Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et dans un modèle préclinique de cancer du côlon lors du congrès Digestive Disease Week 2024 Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et dans un modèle préclinique de cancer du côlon lors du congrès Digestive Disease Week 2024 Abivax Obefazimod Rectocolite Hémorragique Cancer Du Côlon Digestive Disease Week 2024
PRESS RELEASE published on 05/08/2024 at 08:30, 1 year 8 months ago Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024 Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024. The event will showcase new data on obefazimod's impact and mechanism of action Abivax Obefazimod Ulcerative Colitis Colon Cancer Digestive Disease Week 2024
BRIEF published on 05/07/2024 at 22:05, 1 year 8 months ago Abivax Announces Availability of Documents for Upcoming General Meeting Biotechnology Shareholder Information Corporate Governance Abivax General Meeting
BRIEF published on 05/07/2024 at 22:05, 1 year 8 months ago Abivax annonce la mise à disposition des documents pour la prochaine assemblée générale Biotechnologie Abivax Assemblée Générale Gouvernance D'Entreprise Informations Pour Les Actionnaires
PRESS RELEASE published on 05/07/2024 at 22:01, 1 year 8 months ago Abivax assemblée générale ordinaire annuelle et extraordinaire du 30 mai 2024 - Mise à disposition des documents préparatoires Abivax annonce la tenue de son assemblée générale annuelle et extraordinaire le 30 mai 2024 à Paris. Mise à disposition des documents préparatoires pour les actionnaires Biotechnologie Abivax Obefazimod Assemblée Générale Documents Préparatoires
PRESS RELEASE published on 05/07/2024 at 22:00, 1 year 8 months ago Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents Abivax informs shareholders of its ordinary and extraordinary general meeting on May 30, 2024, providing access to preparatory documents and details on participation. Obefazimod and Abivax information included Abivax Obefazimod General Meeting Clinical-stage Biotechnology Preparatory Documents
PRESS RELEASE published on 05/07/2024 at 22:00, 1 year 8 months ago Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents Abivax announces its annual ordinary and extraordinary general meeting on May 30, 2024, with preparatory documents available for shareholders. The meeting details, including agenda and resolutions, are accessible on the company's website Shareholders Biotechnology Abivax General Meeting Preparatory Documents
PRESS RELEASE published on 05/07/2024 at 22:00, 1 year 8 months ago Abivax assemblée générale ordinaire annuelle et extraordinaire du 30 mai 2024 - Mise à disposition des documents préparatoires Abivax annonce son assemblée générale annuelle et extraordinaire du 30 mai 2024 avec la mise à disposition des documents préparatoires. L'événement se tiendra à Paris Biotechnologie Abivax Assemblée Générale Traitements Thérapeutiques Documents Préparatoires
BRIEF published on 04/30/2024 at 18:05, 1 year 9 months ago ABIVAX rapporte le nombre d'actions et de droits de vote au 31 mars 2024 Autorité Des Marchés Financiers Droits De Vote Capital Social Abivax Informations Réglementaires
Published on 02/02/2026 at 23:55, 3 hours 22 minutes ago 2026 Tunkillia Development Drilling Programs Begin
Published on 02/02/2026 at 23:55, 3 hours 22 minutes ago 55 North Mining Announces Winter Exploration Drill Program at Last Hope Gold Project
Published on 02/02/2026 at 23:25, 3 hours 52 minutes ago Western Announces Sale of GlassMasters Investment
Published on 02/02/2026 at 22:05, 5 hours 12 minutes ago Organto Foods to Attend Fruit Logistica 2026 in Berlin, Germany From February 4-6, 2026
Published on 02/02/2026 at 15:00, 12 hours 17 minutes ago Jericho Energy Ventures Strategically Terminates SmartKem LOI to Advance Independent Data Center Energy Infrastructure Platform
Published on 02/02/2026 at 20:00, 7 hours 17 minutes ago CGTN AMERICA & CCTV UN: Cultural Event Celebrating the Spring Festival and the 55th Anniversary of China-U.S. Ping-Pong Diplomacy
Published on 02/02/2026 at 19:57, 7 hours 19 minutes ago US federal court grants preliminary injunction allowing Sunrise Wind construction to resume
Published on 02/02/2026 at 19:42, 7 hours 34 minutes ago EQS-Adhoc: ProSiebenSat.1 publishes preliminary figures for financial year 2025
Published on 02/02/2026 at 19:05, 8 hours 12 minutes ago Virtual Science AI launches the life science industry's first medical congress AI solution for real-time event conversational intelligence
Published on 02/02/2026 at 19:00, 8 hours 17 minutes ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 02/02/2026 at 18:23, 8 hours 53 minutes ago Monthly disclosure of the total number of shares and voting rights - January 2026
Published on 02/02/2026 at 18:23, 8 hours 53 minutes ago TF1 - Déclaration mensuelle des actions et droits de vote - Janvier 2026
Published on 02/02/2026 at 18:00, 9 hours 17 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 02/02/2026 at 18:00, 9 hours 17 minutes ago Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 02/02/2026 at 18:00, 9 hours 17 minutes ago Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social